Astec Lifesciences
Astec Lifesciences Limited, a prominent player in the agrochemical and pharmaceutical sectors, is headquartered in India. Established in 1994, the company has made significant strides in the development and manufacturing of a diverse range of active ingredients and intermediates. With a strong presence in both domestic and international markets, Astec Lifesciences focuses on crop protection, specialty chemicals, and custom synthesis. The company is renowned for its commitment to quality and innovation, offering unique products that cater to the evolving needs of the agricultural and pharmaceutical industries. Notable achievements include a robust portfolio of patented formulations and a reputation for excellence in regulatory compliance. As a key contributor to sustainable agriculture, Astec Lifesciences continues to strengthen its market position through strategic partnerships and a dedication to research and development.
DitchCarbon Score
How does Astec Lifesciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Astec Lifesciences's score of 18 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Astec Lifesciences's reported carbon emissions
In 2023, Astec Lifesciences reported total carbon emissions of approximately 74,046,000 kg CO2e, comprising 23,309,000 kg CO2e from Scope 1, 15,948,000 kg CO2e from Scope 2, and 74,046,000 kg CO2e from Scope 3 emissions. This marked a significant increase in emissions compared to 2022, where the company recorded about 32,353,000 kg CO2e in Scope 1 and 14,547,000 kg CO2e in Scope 2, totalling approximately 46,900,000 kg CO2e. For 2024, Astec Lifesciences projected a reduction in emissions, with Scope 1 emissions at about 19,072,000 kg CO2e, Scope 2 at 16,935,000 kg CO2e, and Scope 3 at 45,092,000 kg CO2e. Despite these figures, the company has not disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or any formal climate pledges. Astec Lifesciences continues to monitor its emissions intensity, reporting a Scope 1 and 2 emission intensity of approximately 4,890 kg CO2e per tonne of physical output in 2023. The company remains committed to improving its sustainability practices, although specific reduction strategies have not been outlined.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 32,353,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 14,547,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Astec Lifesciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
